$CTGO
Contango ORE, Inc.

2023 Q1 Form 10-Q Financial Statement

#000143774923002590 Filed on February 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.981M $2.176M
YoY Change -38.64% -22.19%
% of Gross Profit
Research & Development $378.4K $2.346M
YoY Change -82.36% 70.45%
% of Gross Profit
Depreciation & Amortization $34.21K $34.22K
YoY Change 234.41% 282.77%
% of Gross Profit
Operating Expenses $2.394M $4.557M
YoY Change -55.53% 8.95%
Operating Profit
YoY Change
Interest Expense -$5.532M -$9.752M
YoY Change -178378.44% 1207.1%
% of Operating Profit
Other Income/Expense, Net -$5.529M -$9.749M
YoY Change 263.57% 1314.36%
Pretax Income -$7.925M -$14.31M
YoY Change 14.08% 193.51%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.925M -$14.31M
YoY Change 16.08% 193.51%
Net Earnings / Revenue
Basic Earnings Per Share -$1.09 -$2.10
Diluted Earnings Per Share -$1.09 -$2.10
COMMON SHARES
Basic Shares Outstanding 7.217M 6.775M
Diluted Shares Outstanding 7.243M 6.807M

Balance Sheet

Concept 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.919M $8.765M
YoY Change -63.45% -59.92%
Cash & Equivalents $2.919M $8.765M
Short-Term Investments
Other Short-Term Assets $1.208M $1.048M
YoY Change -16.72% -33.8%
Inventory
Prepaid Expenses $977.4K $816.6K
Receivables
Other Receivables
Total Short-Term Assets $4.127M $9.813M
YoY Change -58.63% -58.65%
LONG-TERM ASSETS
Property, Plant & Equipment $13.41M $13.45M
YoY Change -1.44% -1.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change
Other Assets $13.41M $13.45M
YoY Change -1.44% -1.33%
Total Long-Term Assets $13.41M $13.45M
YoY Change -1.44% -1.33%
TOTAL ASSETS
Total Short-Term Assets $4.127M $9.813M
Total Long-Term Assets $13.41M $13.45M
Total Assets $17.54M $23.26M
YoY Change -25.63% -37.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $74.96K $150.7K
YoY Change -87.2% -61.99%
Accrued Expenses $506.9K $1.255M
YoY Change 1.88% 620.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $581.8K $1.406M
YoY Change -52.51% -79.39%
LONG-TERM LIABILITIES
Long-Term Debt $19.40M $19.35M
YoY Change
Other Long-Term Liabilities $3.284M $3.281M
YoY Change 0.36% 0.35%
Total Long-Term Liabilities $22.68M $22.63M
YoY Change 593.15% 592.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $581.8K $1.406M
Total Long-Term Liabilities $22.68M $22.63M
Total Liabilities $23.26M $24.04M
YoY Change 417.27% 138.22%
SHAREHOLDERS EQUITY
Retained Earnings -$87.86M -$79.93M
YoY Change 71.26% 79.73%
Common Stock $82.06M $79.09M
YoY Change 12.87% 10.13%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change -100.0%
Treasury Stock Shares $0.00
Shareholders Equity -$5.724M -$777.4K
YoY Change
Total Liabilities & Shareholders Equity $17.54M $23.26M
YoY Change -25.63% -37.74%

Cashflow Statement

Concept 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$7.925M -$14.31M
YoY Change 16.08% 193.51%
Depreciation, Depletion And Amortization $34.21K $34.22K
YoY Change 234.41% 282.77%
Cash From Operating Activities -$3.027M -$5.291M
YoY Change -20.81% 36.54%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$5.091M -$9.310M
YoY Change -34.46% 884.9%
Cash From Investing Activities -$5.091M -$9.310M
YoY Change -34.83% 884.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.272M 5.556M
YoY Change -201.01% -8116.45%
NET CHANGE
Cash From Operating Activities -3.027M -5.291M
Cash From Investing Activities -5.091M -9.310M
Cash From Financing Activities 2.272M 5.556M
Net Change In Cash -5.846M -9.044M
YoY Change -57.89% 84.98%
FREE CASH FLOW
Cash From Operating Activities -$3.027M -$5.291M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$3.027M -$5.291M
YoY Change -19.89% 36.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 ctgo Rights Agreement Number Of Preferred Stock Issuable Per Right
RightsAgreementNumberOfPreferredStockIssuablePerRight
0.001
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7101395
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7101395
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6860420
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6769923
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
90497
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-689282 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9835876 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2190389 usd
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35770
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3431051
dei Entity Address Address Line1
EntityAddressAddressLine1
3700 BUFFALO SPEEDWAY, SUITE 925
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77098
dei City Area Code
CityAreaCode
713
dei Local Phone Number
LocalPhoneNumber
877-1311
dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.01 per share
dei Trading Symbol
TradingSymbol
CTGO
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7217368
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8765154 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23095101 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
231000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
231000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
816596 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
453353 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
9812750 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
23779454 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
0 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13446822 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13514531 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13446822 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13514531 usd
CY2022Q4 us-gaap Assets
Assets
23259572 usd
CY2022Q2 us-gaap Assets
Assets
37293985 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
150677 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
633856 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1254837 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
870981 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1405514 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1504837 usd
CY2022Q4 ctgo Advance Royalty Reimbursement Noncurrent
AdvanceRoyaltyReimbursementNoncurrent
1200000 usd
CY2022Q2 ctgo Advance Royalty Reimbursement Noncurrent
AdvanceRoyaltyReimbursementNoncurrent
1200000 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
234056 usd
CY2022Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
228082 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1847063 usd
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1847063 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19350322 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19239960 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
22631441 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
22515105 usd
CY2022Q4 us-gaap Liabilities
Liabilities
24036955 usd
CY2022Q2 us-gaap Liabilities
Liabilities
24019942 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
71014 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
68604 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
79086142 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74057859 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
-0 usd
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2318182 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79934539 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58534238 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-777383 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
13274043 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23259572 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37293985 usd
CY2022Q4 ctgo Claim Rental Expense
ClaimRentalExpense
126451 usd
CY2021Q4 ctgo Claim Rental Expense
ClaimRentalExpense
157163 usd
ctgo Claim Rental Expense
ClaimRentalExpense
273376 usd
ctgo Claim Rental Expense
ClaimRentalExpense
306973 usd
CY2022Q4 us-gaap Exploration Expense
ExplorationExpense
2219913 usd
CY2021Q4 us-gaap Exploration Expense
ExplorationExpense
1219437 usd
us-gaap Exploration Expense
ExplorationExpense
6616483 usd
us-gaap Exploration Expense
ExplorationExpense
2165682 usd
CY2022Q4 us-gaap Depreciation Nonproduction
DepreciationNonproduction
34214 usd
CY2021Q4 us-gaap Depreciation Nonproduction
DepreciationNonproduction
8933 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
68428 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
13715 usd
CY2022Q4 us-gaap Accretion Expense
AccretionExpense
2948 usd
CY2021Q4 us-gaap Accretion Expense
AccretionExpense
3560 usd
us-gaap Accretion Expense
AccretionExpense
5974 usd
us-gaap Accretion Expense
AccretionExpense
3560 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2176097 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2796664 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4600164 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4766933 usd
CY2022Q4 us-gaap Costs And Expenses
CostsAndExpenses
4559623 usd
CY2021Q4 us-gaap Costs And Expenses
CostsAndExpenses
4185757 usd
us-gaap Costs And Expenses
CostsAndExpenses
11564425 usd
us-gaap Costs And Expenses
CostsAndExpenses
7256863 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
7799 usd
CY2021Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
494 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
16344 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
991 usd
CY2022Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-446707 usd
CY2021Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
53224 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-896177 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3380 usd
CY2022Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9310000 usd
CY2021Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-743000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9310000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2188000 usd
CY2022Q4 us-gaap Insurance Recoveries
InsuranceRecoveries
0 usd
CY2021Q4 us-gaap Insurance Recoveries
InsuranceRecoveries
0 usd
us-gaap Insurance Recoveries
InsuranceRecoveries
338301 usd
us-gaap Insurance Recoveries
InsuranceRecoveries
0 usd
CY2022Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2021Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
15656 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9748908 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14308531 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4875039 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21400301 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9447252 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-14308531 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-4875039 usd
us-gaap Net Income Loss
NetIncomeLoss
-21400301 usd
us-gaap Net Income Loss
NetIncomeLoss
-9447252 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.10
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.41
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6807317
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6751581
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6787864
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6716076
us-gaap Net Income Loss
NetIncomeLoss
-21400301 usd
us-gaap Net Income Loss
NetIncomeLoss
-9447252 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1598421 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2278160 usd
us-gaap Depreciation
Depreciation
68428 usd
us-gaap Depreciation
Depreciation
13715 usd
us-gaap Accretion Expense
AccretionExpense
5974 usd
us-gaap Accretion Expense
AccretionExpense
3560 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9310000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2188000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
335047 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
363243 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
721162 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-100043 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
337558 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-0 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
80000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10545717 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5427421 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
9310000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
2188000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5393305 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9310000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7581318 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
86932 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
69307 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
14202 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5525770 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-112867 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14239947 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13121606 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23326101 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35220588 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8996154 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22098982 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
716687 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
80000 usd
us-gaap Stock Issued1
StockIssued1
238886 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Notes Issued1
NotesIssued1
0 usd
us-gaap Notes Issued1
NotesIssued1
6250000 usd
ctgo Transaction Costs Incurred For Acquisition Financed In Accounts Payable
TransactionCostsIncurredForAcquisitionFinancedInAccountsPayable
0 usd
ctgo Transaction Costs Incurred For Acquisition Financed In Accounts Payable
TransactionCostsIncurredForAcquisitionFinancedInAccountsPayable
719 usd
ctgo Asset Retirement Obligations Noncash Transaction
AssetRetirementObligationsNoncashTransaction
0 usd
ctgo Asset Retirement Obligations Noncash Transaction
AssetRetirementObligationsNoncashTransaction
218927 usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1847063 usd
ctgo Fair Value Of Investing Activities Assumed
FairValueOfInvestingActivitiesAssumed
238886 usd
ctgo Fair Value Of Investing Activities Assumed
FairValueOfInvestingActivitiesAssumed
8316709 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
13274043 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
787874 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
27693 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7091770 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7081340 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
810547 usd
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2847092 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
657105 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
71500 usd
CY2022Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
59239 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-14308531 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-777383 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
34548775 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1021851 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
43560 usd
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4572213 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
30954853 usd
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1256309 usd
CY2021Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2021Q4 ctgo Adjustments To Additional Paid In Capital Treasury Shares Withheld For Employee Taxes
AdjustmentsToAdditionalPaidInCapitalTreasurySharesWithheldForEmployeeTaxes
-69307 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-4875039 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
27266816 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><b><span style="background-color:#ffffff;"><em style="font: inherit;">2.</em></span><span style="background-color:#ffffff;"> Basis of Presentation</span></b></p> <p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </p> <p style="margin: 0pt; text-align: justify; text-indent: 24pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><span style="background-color:#ffffff;"> The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), including instructions to Form </span><span style="background-color:#ffffff;"><em style="font: inherit;">10</em></span><span style="background-color:#ffffff;">-Q and Article </span><span style="background-color:#ffffff;"><em style="font: inherit;">8</em></span><span style="background-color:#ffffff;"> of Regulation S-</span><span style="background-color:#ffffff;"><em style="font: inherit;">X.</em></span><span style="background-color:#ffffff;"> Accordingly, they do </span><span style="background-color:#ffffff;"><em style="font: inherit;">not</em></span><span style="background-color:#ffffff;"> include all the information and footnotes required by US GAAP for complete annual consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation of the consolidated financial statements have been included. All such adjustments are of a normal recurring nature. The consolidated financial statements should be read in conjunction with the consolidated audited financial statements and notes included in the Company</span><span style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><span style="background-color:#ffffff;">’s Form </span><span style="background-color:#ffffff;"><em style="font: inherit;">10</em></span><span style="background-color:#ffffff;">-K for the fiscal year ended </span><em style="font-style: normal; font-weight: inherit;"><span style="background-color:#ffffff;"> June </span></em><span style="background-color:#ffffff;"><em style="font: inherit;">30,</em></span><span style="background-color:#ffffff;"><em style="font: inherit;">2022.</em></span><span style="background-color:#ffffff;"> The results of operations for the </span><span style="background-color:#ffffff;"><em style="font: inherit;">three</em> and <em style="font: inherit;">six</em> months</span><span style="background-color:#ffffff;"> ended </span><em style="font-style: normal; font-weight: inherit;"><span style="background-color:#ffffff;"> December 31, 2022 </span></em><span style="background-color:#ffffff;">are </span><span style="background-color:#ffffff;"><em style="font: inherit;">not</em></span><span style="background-color:#ffffff;"> necessarily indicative of the results that </span><em style="font-style: normal; font-weight: inherit;"><span style="background-color:#ffffff;"> may </span></em><span style="background-color:#ffffff;">be expected for the fiscal year ending </span><em style="font-style: normal; font-weight: inherit;"><span style="background-color:#ffffff;"> June </span></em><span style="background-color:#ffffff;"><em style="font: inherit;">30,</em></span><span style="background-color:#ffffff;"><em style="font: inherit;">2023.</em></span></span></p>
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
816596 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
453353 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14308531 usd
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6807317
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.10
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4875039 usd
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6751581
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-14308531 usd
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6807317
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.10
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-4875039 usd
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6751581
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21400301 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6787864
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.15
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9447252 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6716076
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.41
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21400301 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6787864
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.15
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9447252 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6716076
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.41
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
383500
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7101395
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
383500
CY2020Q4 ctgo Rights Agreement Exercise Price
RightsAgreementExercisePrice
100.00
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
124168 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
55740 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
115025 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
115025 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13446822 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13514531 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
810547 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1598421 usd
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1256309 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2278160 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y7D
CY2019Q1 ctgo Contingent Salary And Compensation Retention Agreement
ContingentSalaryAndCompensationRetentionAgreement
1500000 usd
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
47000 usd

Files In Submission

Name View Source Status
0001437749-23-002590-index-headers.html Edgar Link pending
0001437749-23-002590-index.html Edgar Link pending
0001437749-23-002590.txt Edgar Link pending
0001437749-23-002590-xbrl.zip Edgar Link pending
conta20221231c_10q.htm Edgar Link pending
ctgo-20221231.xsd Edgar Link pending
ex_467675.htm Edgar Link pending
ex_467676.htm Edgar Link pending
ex_467677.htm Edgar Link pending
ex_467678.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
conta20221231c_10q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ctgo-20221231_cal.xml Edgar Link unprocessable
ctgo-20221231_lab.xml Edgar Link unprocessable
ctgo-20221231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ctgo-20221231_pre.xml Edgar Link unprocessable